Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueInventory Average

RedHill Biopharma (RDHL) FCF Margin (2016 - 2022)

Historic FCF Margin for RedHill Biopharma (RDHL) over the last 11 years, with Q4 2022 value amounting to 18.92%.

  • RedHill Biopharma's FCF Margin rose 483900.0% to 18.92% in Q4 2022 from the same period last year, while for Dec 2023 it was 13.31%, marking a year-over-year increase of 336000.0%. This contributed to the annual value of 0.0% for FY2024, which is 5483800.0% up from last year.
  • According to the latest figures from Q4 2022, RedHill Biopharma's FCF Margin is 18.92%, which was up 483900.0% from 34.22% recorded in Q3 2022.
  • RedHill Biopharma's 5-year FCF Margin high stood at 18.92% for Q4 2022, and its period low was 983.14% during Q1 2020.
  • Moreover, its 5-year median value for FCF Margin was 88.72% (2021), whereas its average is 297.97%.
  • Examining YoY changes over the last 5 years, RedHill Biopharma's FCF Margin showed a top increase of 16356400bps in 2018 and a maximum decrease of -210318500bps in 2018.
  • RedHill Biopharma's FCF Margin (Quarter) stood at 602.58% in 2018, then plummeted by -44bps to 870.19% in 2019, then surged by 93bps to 58.97% in 2020, then dropped by -14bps to 67.31% in 2021, then skyrocketed by 72bps to 18.92% in 2022.
  • Its FCF Margin was 18.92% in Q4 2022, compared to 34.22% in Q3 2022 and 89.49% in Q2 2022.